Clinical Trial Update: A Trial Evaluating the Efficacy and Safety of HLD200 in Children With ADHD [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating HLD200 for efficacy and safety in children with ADHD has completed and results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Attention Deficit Hyperactivity Disorder

Drugs mentioned

• HLD200

Snippet

Sponsor: Ironshore Pharmaceuticals and Development, Inc | Conditions: Attention Deficit Hyperactivity Disorder | Phase 3 | Status: COMPLETED | Results posted: 2021-02-10